Telomerase contributes to fludarabine resistance in primary human leukemic lymphocytes.
We report that Imetelstat, a telomerase inhibitor that binds to the RNA component of telomerase (hTR), can sensitize primary CLL lymphocytes to fludarabine in vitro. This effect was observed in lymphocytes from clinically resistant cases and with cytogenetic abnormalities associated with bad prognos...
Main Authors: | May Shawi, Tsz Wai Chu, Veronica Martinez-Marignac, Y Yu, Sergei M Gryaznov, James B Johnston, Susan P Lees-Miller, Sarit E Assouline, Chantal Autexier, Raquel Aloyz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3726637?pdf=render |
Similar Items
-
Telomerases : chemistry, biology, and clinical applications /
by: Lue, Neal, 1962-, et al.
Published: (c201) -
Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients
by: Szymczyk A, et al.
Published: (2019-05-01) -
Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia
by: Ann Janssens, et al.
Published: (2009-10-01) -
Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes
by: Gabriela Galicia-Vázquez, et al.
Published: (2018-09-01) -
T-cell large granular lymphocytic leukemia: treatment experience with fludarabine
by: Renata Oliveira Costa, et al.
Published: (2012-07-01)